Group 1 - The core point of the article is that Hualan Biological Engineering Co., Ltd. (华兰股份) is currently experiencing a decline in stock price, with a closing price of 32.80 yuan and a drop of 3.53%, resulting in a total market value of 5.386 billion yuan, indicating that the stock is in a state of loss [1] - Hualan shares were listed on the Shenzhen Stock Exchange's Growth Enterprise Market on November 1, 2021, with an initial public offering of 33.66667 million shares, accounting for 25% of the total share capital after issuance, at a price of 58.08 yuan per share [1] - The total funds raised by Hualan during the IPO amounted to 1.955 billion yuan, with a net amount of 1.804 billion yuan, exceeding the original plan by 1.254 billion yuan [1] - The company planned to use the raised funds for automation and intelligent factory renovation projects, research and development center construction, and to supplement working capital [1] Group 2 - Hualan's issuance costs were 151 million yuan, with Huatai United Securities Co., Ltd. receiving underwriting and sponsorship fees of 133 million yuan [2] - The company announced a dividend distribution plan for the year 2024, proposing a cash dividend of 2 yuan for every 10 shares and a capital reserve conversion of 3 shares for every 10 shares, with the record date for the dividend being July 11, 2025 [2] - The ex-dividend date is set for July 14, 2025, and the trading of the newly issued shares will also commence on the same date [2]
华兰股份跌3.53% 2021年上市超募12.5亿元